For All The Daily News, Views, & Trending Stories, Download in60 App Today!
brain-in60-2.jpg May 26

Elon Musk's Neuralink Announces FDA Approval Of In-Human Clinical Study

  • Neuralink, the neurotech startup co-founded by Elon Musk, announced Thursday it has received approval from the FDA to conduct its first in-human clinical study.
  • The implant aims to help patients with severe paralysis regain their ability to communicate by controlling external technologies using only neural signals.
  • The extent of the approved trial is not known.
  • Neuralink said in a tweet that patient recruitment for its clinical trial is not open yet.